A

Aptose Biosciences Inc
TSX:APS

Watchlist Manager
Aptose Biosciences Inc
TSX:APS
Watchlist
Price: 2.08 CAD -3.26% Market Closed
Market Cap: 37.7m CAD

Net Margin
Aptose Biosciences Inc

0%
Current
0%
Average
-6.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-35.8m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Aptose Biosciences Inc
Glance View

Market Cap
37.7m CAD
Industry
Biotechnology

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. The company is headquartered in North York, Ontario and currently employs 41 full-time employees. The firm has two clinical-stage investigational products for hematologic malignancies: luxeptinib and APTO-253. The luxeptinib is a mutation agnostic Bruton’s tyrosine kinase (BTK) kinase inhibitor, which is in a Phase I a/b trial in patients with refractory B cell malignancies, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL) and non-Hodgkin lymphoma (NHL), who have failed or are intolerant to standard therapies and is in a separate Phase I a/b trial in patients with refractory acute myeloid leukemia (AML). Its APTO-253 is the clinical stage agent that directly targets the Master Regulator of Cell Cycle Entry and Proliferative Metabolism (MYC) oncogene and suppresses its expression, which is in a Phase I a/b clinical trial for the treatment of patients with relapsed.

APS Intrinsic Value
Not Available
A
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-35.8m
/
Revenue
0
What is the Net Margin of Aptose Biosciences Inc?

Based on Aptose Biosciences Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top